Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient/parent global activity, manual muscle testing (mmt) …

LG Rider, VP Werth, AM Huber… - Arthritis care & …, 2011 - Wiley Online Library
The idiopathic inflammatory myopathies, including adult and juvenile dermatomyositis (DM),
polymyositis (PM), and inclusion body myositis (IBM), are rare systemic autoimmune …

Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood

BM Feldman, LG Rider, AM Reed, LM Pachman - The Lancet, 2008 - thelancet.com
Juvenile dermatomyositis, the most common inflammatory myopathy of childhood, is a rare
systemic autoimmune vasculopathy that is characterised by weakness in proximal muscles …

Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications

Y Ye, Z Chen, S Jiang, F Jia, T Li, X Lu, J Xue… - Nature …, 2022 - nature.com
Anti-melanoma differentiation-associated gene 5-positive dermatomyositis (MDA5+ DM) is
an autoimmune condition associated with rapidly progressive interstitial lung disease and …

239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018

AL Mammen, Y Allenbach, W Stenzel… - Neuromuscular …, 2020 - Elsevier
Idiopathic inflammatory myopathies (IIM) are a heterogenous family of diseases that can
affect the muscles, skin, lungs, and joints. There have been prior attempts to classify IIMs …

119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003 …

JE Hoogendijk, AA Amato, BR Lecky, EH Choy… - Neuromuscular …, 2004 - Elsevier
Polymyositis (PM) and dermatomyositis (DM) are idiopathic inflammatory myopathies (IIMs)
with an autoimmune pathogenesis. Typical features are subacute-onset, proximal …

BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic …

DA Isenberg, A Rahman, E Allen, V Farewell… - …, 2005 - academic.oup.com
Objective. To devise a more discriminating version of the British Isles Lupus Assessment
Group (BILAG) disease activity index and to show that it is reliable. Methods. A nominal …

The EuroMyositis registry: an international collaborative tool to facilitate myositis research

JB Lilleker, J Vencovsky, G Wang… - Annals of the …, 2018 - ard.bmj.com
Aims The EuroMyositis Registry facilitates collaboration across the idiopathic inflammatory
myopathy (IIM) research community. This inaugural report examines pooled Registry data …

Long‐term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients

A Ravelli, L Trail, C Ferrari, N Ruperto… - Arthritis Care & …, 2010 - Wiley Online Library
Objective To investigate the long‐term outcome and prognostic factors of juvenile
dermatomyositis (DM) through a multinational, multicenter study. Methods Patients consisted …

Pathogenic role of anti–signal recognition protein and anti–3‐Hydroxy‐3‐methylglutaryl‐C o A reductase antibodies in necrotizing myopathies: Myofiber atrophy and …

L Arouche‐Delaperche, Y Allenbach… - Annals of …, 2017 - Wiley Online Library
Objective Immune‐mediated necrotizing myopathies (IMNM) may be associated with either
anti–signal recognition protein (SRP) or anti–3‐hydroxy‐3‐methylglutaryl‐CoA reductase …

Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis

PA Gordon, JB Winer, JE Hoogendijk… - Cochrane Database …, 2012 - cochranelibrary.com
Background Idiopathic inflammatory myopathies are chronic diseases with significant
mortality and morbidity. Whilst immunosuppressive and immunomodulatory therapies are …